AbetaPP-Selective BACE Inhibitors (ASBI): Novel Class of Therapeutic Agents for Alzheimer's Disease

Manuscript Number: 

13-0578R1

Author(s): 
Dale E. Bredesen, Jesus Campagna, Olivier Descamps, Olivia Gorostiza, Barbara Jagodzinska, Varghese John, Clare P. Libeu, Karen S. Poksay, Patricia Spilman, Qiang Zhang

Disclosures

Dale E. Bredesen

  • Nothing to Disclose

Jesus Campagna

  • Nothing to Disclose

Olivier Descamps

  • Nothing to Disclose

Olivia Gorostiza

  • Nothing to Disclose

Barbara Jagodzinska

  • Consulting Fees:
    $1000/mo

Varghese John

  • Nothing to Disclose

Clare P. Libeu

  • Nothing to Disclose

Karen S. Poksay

  • Nothing to Disclose

Patricia Spilman

  • Nothing to Disclose

Qiang Zhang

  • Nothing to Disclose